Lopinavir CAS 192725-17-0 API Anti-HIV HIV Protease Inhibitor COVID-19 Tino Ma

Whakaahuatanga Poto:

Ingoa matū: Lopinavir

CAS: 192725-17-0

Te ahua: Ma ki te Paura Paura Ma

Whakamātautau (HPLC): 98.0%~102.0%

Tohua Peptidomimetic HIV-1 Protease Inhibitor

API Kounga Teitei, Hanganga Tauhokohoko

Inquiry: alvin@ruifuchem.com


Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Ko te Kaihanga Kaihanga me te Maama me te Kounga Pumau
Ingoa matū: Lopinavir
CAS: 192725-17-0
He Tino Kaha, Ko te Peptidomimetic HIV-1 Protease Inhibitor
Hua Rangahau e Pa ana ki te COVID-19
API Kounga Teitei, Hanganga Tauhokohoko

Ngā Āhuatanga matū:

Ingoa matū Lopinavir
Nga kupu taurite LPV;ABT-378;Kaletra
Tau CAS 192725-17-0
Tau CAT RF-API73
Tūnga Taonga Kei roto i nga taonga, ka eke ki te rau kirokaramu
Tātai rāpoi C37H48N4O5
Taumaha rāpoi 628.81
Rokiroki mo te wa roa Rokiroki mo te wa roa ki te 2-8 ℃
Waitohu Ruifu Chemical

Whakatakotoranga:

Tūemi Whakatakotoranga
Te ahua Ma ki te Paura-White
Wairewa Ka Rere noa ki te Mewaro me te Ewaro, Ka Rere ki te 2-Propanol
Tautuhinga IR Ko te awhi infrared absorption o te tauira whakamatautau he rite ki te paerewa tohutoro
Tautuhinga HPLC Ko te wa pupuri o te tauira whakamatautau ka rite ki tera o te paerewa tohutoro
Ihirangi Wai (na KF) ≤4.0%
Hurihanga Optical Tauwhāiti -22.0° ki te -26.0°
Te toenga i runga i te mura ≤0.20%
Nga Korewa Taamaha ≤20ppm
Iwi Whakarewa 124.0 ki te 127.0 ℃
Te pungarehu whanariki ≤0.20%
Wehenga toenga (Ewaro) ≤0.50%
Nga Taonga Paanga (HPLC, Rohe%)
poke 1
Parakore B (RRT=0.07) ≤0.20%
Te poke I (RRT=1.10) ≤0.20%
Tetahi atu poke ≤0.10%
poke 2
Tetahi atu poke takitahi ≤0.10%
Ko nga poke katoa mai i te Tikanga 1 me te 2 ≤0.70%
Nga poke katoa ≤1.0%
Whakamātautau (na HPLC) 98.0%~102.0%
Paerewa Whakamatau Paerewa hinonga
Whakamahinga Tohua Peptidomimetic HIV-1 Protease Inhibitor, Hua Rangahau e Pa ana ki te COVID-19

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, Pahu Kaata, 25kg / Drum, kia rite ranei ki te hiahia a te kaihoko.

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Whakaorangia mai i te marama, te makuku me te mate kino.

Painga:

1

FAQ:

Taupānga:

Ko te Lopinavir (ABT-378) he tino kaha, he aukati peptidomimetic whiriwhiri o te HIV-1 protease, me te Kis o 1.3 ki te 3.6 pM mo te momo mohoao me te mutant HIV protease.Ka mahi a Lopinavir ma te hopu i te pakeketanga o te HIV-1 ma reira ka aukati i tana mate.Ko Lopinavir ano hoki he aukati SARS-CoV 3CLpro me te IC50 o te 14.2 μM.Ko te Lopinavir he antiretroviral o te karaehe aukati protease.Ko te aukati o te HIV-1 protease ka aukati i te wehenga o te polyprotein viral precursor ka puta te tukunga o nga virion kore-pakeke.He waahanga o te rongoa whakakotahi hei rongoa i te HIV/AIDS.Ko Lopinavir, te tuaono o te HIV protease inhibitor i roto i te karaehe "navir", i whakarewahia i roto i te whakakotahitanga me te ritonavir, tetahi atu aukati HIV protease kua hokona kua hokona (Abbott, 1996);i whakauruhia tenei hanganga taketake hei Kaletra mo te whakamahi i te taha o te nucleoside, te kore-nucleoside reverse transcriptase inhibitors mo te maimoatanga o te AIDS i roto i nga pakeke me nga tamariki.Ko te Lopinavir he puhui peptidomimetic he rite tonu te hanganga ki tera o te ritonavir, i whakaurua mai nga roopu mutunga, ina koa he valine kua whakarereketia e nga tikanga honohono peptide.Ko te Lopinavir he aukati whakataetae kaha mo te HIV-I protease e whakaatu ana i te kaha nui ki te whakarereke i te ritonavir-aukati.I roto i te maha o nga momo kararehe, ko nga rangahau pharmacokinetic me te hononga lopinavirlritonavir i whakaatu ko nga ahuatanga ngawari o te lopinavir i tino pai ake i te aroaro o te ritonavir, mo te Cmax me te roa o te mahi.

Tuhia to korero ki konei ka tukuna mai ki a matou